How can today’s CDMOs ensure they can meet tomorrow's demands?

NEW INTERVIEW! We are pleased to share some highlights from our conversation with Michelle Logan from Thermo Fisher Scientific at CPHI 2025!

In our conversation, Michelle talks about the exciting expansion of their U.S. capacity for sterile fill-finish services, particularly focusing on the Ridgefield facility and its impressive capabilities. She also shares insights on the new development lines at the Plainville site, which will enhance collaboration with biotech companies in the Boston area.

3 0

At CPHI, Martin Meeson and Arul Ramadurai revealed how Axplora is scaling new frontiers in API manufacturing — backed by €100M+ invested this year and the confidence of 900+ customers across the globe, including 8 of the world’s top 10 pharma companies.

13 FDA approvals in the past 5 years. 30 years of pioneering cGMP expertise. And a mission that keeps raising the bar in delivery for patients.

2 0

Alway great to talk to Subodh Deshmukh, CEO of Aragen Bioscience, a CRO and CDMO specialising in biologics. Subodh shared insights on Aragen's new production facility, the evolution into a full-scale CDMO, and how they ensure speed, quality, and affordability for clients.

0 0

In this interview, we're joined by Jonathan Guiter, who leads business development for CDMO services at Indena. Jonathan gives us a closer look at Indena, an Italian company that specializes in manufacturing complex and high potent active pharmaceutical ingredients. He shares how Indena supports biotech and pharma companies through every stage of production, from clinical trials to commercial output.

2 0

In this interview, we talked with Shilpa, the Vice President at Enzene Biosciences. Shilpa shares her thoughts on the shift from traditional manufacturing to a more innovative, continuous approach, and how Enzene promotes collaboration and creativity within their R&D team. Join us as we explore the exciting developments at Enzene and Shilpa's vision for the future.

6 0

We are pleased to introduce you to Dr. Ivy Gao, CEO of Sunresin, a pioneering company in resin technology for bioprocessing and life sciences. With their recent nomination for CPHI's Women of the Year Award, Ivy shares insights into her leadership journey, Sunresin’s innovative growth strategies, and her vision for a sustainable future in biopharmaceutical manufacturing.

2 0

We are please to share a recent interview with Joerg Ahlgrimm, CEO of SK Pharmteco. In this conversation, Joerg discusses the company's strategic expansion in peptides, their investments across Asia, Europe, and the US, and their recent partnership with Lotte Biologics to advance antibody drug conjugates. He also shares his vision for SK Pharmteco’s growth and leadership in the biotech CDMO space over the next few years.

4 0

Welcome to our exclusive interview with Paolo Paissoni and Dave Short of Procos S.P.A., a leading Contract Development and Manufacturing Organization (CDMO). As the company celebrated its 80th anniversary, we discussed how strategic investments and a commitment to innovation are shaping its future.

Join us as Paolo and Dave share insights into Procos' journey, exploring the significance of their new state-of-the-art R11 facility and their unique approach to customer partnerships.

0 0